Making the Way for Innovation

(W7) AMCP Talks: Future Trends in Health Technology and Digital Therapeutics

Monday, October 19, 2020

1:00pm – 2:30pm

ACPE UAN:N/A | Contact Hours: N/A | Activity Type:
N/A

Faculty(s)

Susan Bratton, BA, MBA

Chief Executive Officer
Savor Health
New York, New York
Kelsey Moss, PharmD

Population Health Pharmacist
Highmark Health
Pittsburgh, Pennsylvania
Alif Saleh

CEO
Scipher Medicine
Waltham, Massachusetts
Kerri Petrin, MPH

VP, Strategy and Business Development
RxAnte, Inc.
Washington, District of Columbia
David Veenstra, PharmD, PhD

Professor
University of Washington
Seattle, Washington

Moderator(s)

Joseph Honcz, RPh MBA

Principal
C4i
Milford, Connecticut

Please note this session is not accredited for continuing pharmacy education credit.

AMCP is proud to once again offer AMCP Talks, an innovative education opportunity that mixes short, focused presentations with an interactive panel discussion. For AMCP Nexus 2020 Virtual, AMCP Talks will focus on health information technology and digital therapeutics.

It is no secret that the role of information technology continues to evolve and become increasingly sophisticated. Today, health professionals have access to unprecedented data and can use this information to impact patient outcomes. Digital therapeutics are a new and exciting way to use technology to further engage patients in their treatment and help the medical team support their care. To help payers understand how technology and digital therapeutics are being used and what the future may look like, please join us for this interactive, engaging discussion.

During this session, participants will hear from industry leaders who are using information, technology, and digital therapeutics to engage patients, improve outcomes, and support value-based care. You will hear real-life examples of what these leaders are doing. What has worked? What hasn’t worked? What outcomes are patients experiencing? Come find out!

Agenda:

1-1:10pm Welcome and introduction to AMCP Talks

1:10-1:55pm Presentations
   1. Reducing Waste and Improving Drug Response With Machine Learning-Based Precision Diagnostic.
   2. What is the Value of Broad Genomic Profiling in Oncology and How Can it Be Measured in Risk-Sharing Agreements?
   3. Diabetes Deprescribing to Improve Outcomes
   4. Leveraging Analytics in Pharmacy Care: How Therapeutic Decision Support Can Improve Outcomes for Medicare
       Advantage Prescription Drug Plans and Members
   5. Leveraging Artificial Intelligence to Deliver Cost Effective “Nutrition as Intervention and Symptom Management” in
        Chronic Disease

1:55-2:25pm Panel discussion: Perspectives on Health Technology and Digital Therapeutics

2:25-2:30pm Closing remarks/program feedback

Learning Objectives: :

At the completion of this activity, participants should be able to:

Explain data-driven method of guiding patients to best course of treatment while also managing Tumor Necrosis Factor Inhibitors spend.
Discuss how value components of broad genomic profiling in oncology can be communicated and applied to performance-based risk sharing arrangements.
Describe new methods to identify diabetes deprescribing patient opportunities for primary care physicians to provide cost effective, high-value care to members by improving patient safety, reducing costs, and ensuring appropriate medication management.
Describe how analytics can support a patient-centered pharmacy service to make taking multiple medications simpler, safer, and more affordable.
Discuss how artificial intelligence, expert knowledge and clinical best practices, can effectively and affordably deliver chronic disease patients with personalized nutrition interventions and symptom management improving treatment adherence, outcomes, while reducing utilization and costs.